122 related articles for article (PubMed ID: 2124501)
1. Fixed dose short course mitomycin C with vincristine in advanced pre-treated breast cancer.
Millward MJ; Hendrick A; Cantwell BM
Ann Oncol; 1990 Sep; 1(5):373-4. PubMed ID: 2124501
[No Abstract] [Full Text] [Related]
2. Vincristine, adriamycin, and mitomycin (VAM) therapy for previously treated breast cancer. A preliminary report.
Oster MW; Park Y
Cancer; 1983 Jan; 51(2):203-5. PubMed ID: 6821812
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy with BCNU, vincristine, mitomycin-C and prednisone in refractory breast carcinoma. A pilot study.
DiBella NJ; Garfield D; Fink K; Anderson P; Speer J; Murphy J
Oncology; 1984; 41(1):1-3. PubMed ID: 6422372
[TBL] [Abstract][Full Text] [Related]
4. Adriamycin, vincristine and mitomycin C as first and second line therapy for advanced breast carcinoma.
Harding M; Sangster G; Milsted RA; Kaye SB; Calman KC
Med Oncol Tumor Pharmacother; 1988; 5(2):125-8. PubMed ID: 3412036
[TBL] [Abstract][Full Text] [Related]
5. Adriamycin (doxorubicin), vinblastine, and mitomycin C combination chemotherapy in refractory breast carcinoma.
Luikart SD; Witman GB; Portlock CS
Cancer; 1984 Oct; 54(7):1252-5. PubMed ID: 6467151
[TBL] [Abstract][Full Text] [Related]
6. [Vincristine, adriamycin, mitomycin-C and UFT (VAM-UFT) therapy in progressive or recurrent breast cancer].
Yasutake K; Imamura Y; Yoshimura Y; Oya M; Matsushita K; Hozumi T; Katou J; Okutani T; Irie K
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2373-9. PubMed ID: 2502072
[TBL] [Abstract][Full Text] [Related]
7. 5-Fluorouracil + Oncovin + Adriamycin + mitomycin C (FOAM): an effective program for breast cancer, even for disease refractory to previous chemotherapy. A Northern California Oncology Group (NCOG) Study.
Friedman MA; Marcus FS; Cassidy MJ; Resser KJ; Kohler M; Hendrickson CG; Reynolds R; Johnson D; Kilbridge T; Yu K; Cruicitt M
Cancer; 1983 Jul; 52(2):193-7. PubMed ID: 6344976
[TBL] [Abstract][Full Text] [Related]
8. Second and third line chemotherapy in advanced breast cancer.
Alexopoulos A; Rigatos G; Stavrinidis E; Stavrakakis J; Scartsilas C; Papacharalambous A
J Chemother; 1989 Jul; 1(4 Suppl):1189-90. PubMed ID: 16312828
[No Abstract] [Full Text] [Related]
9. A review of mitomycin regimens in advanced breast cancer therapy.
Legha SS
Clin Ther; 1985; 7(3):286-307. PubMed ID: 3888391
[TBL] [Abstract][Full Text] [Related]
10. [Pilot study of multi-cyclic combination chemotherapy in small cell lung cancer].
Kurane S; Kobayashi K; Nukariya N; Morikawa T; Hino M; Sibuya M; Niitani H
Gan To Kagaku Ryoho; 1991 Mar; 18(3):489-92. PubMed ID: 1848422
[No Abstract] [Full Text] [Related]
11. A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer.
Powles TJ; Jones AL; Judson IR; Hardy JR; Ashley SE
Br J Cancer; 1991 Aug; 64(2):406-10. PubMed ID: 1892775
[TBL] [Abstract][Full Text] [Related]
12. Mitomycin C and 5-fluorouracil as second choice treatment in advanced breast cancer patients.
Ardizzoni A; Pronzato P; Conte PF; Rosso R
Chemioterapia; 1984 Apr; 3(2):83-5. PubMed ID: 6442624
[TBL] [Abstract][Full Text] [Related]
13. Vincristine, doxorubicin and mitomycin (VAM) in patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate and fluorouracil (CMF). A clinical trial of the Piedmont Oncology Association (POA).
Shipp SK; Muss HB; Westrick MA; Cooper MR; Jackson DV; Richards FC; White DR; Stuart JJ; Christian RM; Ramseur W
Cancer Chemother Pharmacol; 1983; 11(2):130-3. PubMed ID: 6354509
[TBL] [Abstract][Full Text] [Related]
14. Adriamycin and mitomycin C as initial chemotherapy for advanced breast cancer.
Amiel SA; Stewart JF; Earl HM; Knight RK; Rubens RD
Eur J Cancer Clin Oncol; 1984 May; 20(5):631-4. PubMed ID: 6428893
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of doxorubicin alone or combined with vincristine and mitomycin C in women with metastatic breast cancer.
Ingle JN; Mailliard JA; Schaid DJ; Krook JE; Gerstner JB; Pfeifle DM; Marschke RF; Long HJ; McCormack GW; Foley JF
Am J Clin Oncol; 1989 Dec; 12(6):474-80. PubMed ID: 2686393
[TBL] [Abstract][Full Text] [Related]
16. Mitomycin and tamoxifen versus mitolactol, doxorubicin, and tamoxifen in patients with previously treated breast cancer.
Falkson G; Gelman RS; Tormey DC; Taylor SG; Falkson HC
Cancer Treat Rep; 1985; 69(7-8):755-60. PubMed ID: 4016786
[TBL] [Abstract][Full Text] [Related]
17. Dibromodulcitol, mitomycin C and vinblastine (DMV) chemotherapy in advanced breast cancer.
Howell A; Morrison JM; Bramwell VH; Harland RN; Moneypenny IJ
Eur J Cancer Clin Oncol; 1984 Jul; 20(7):873-6. PubMed ID: 6540188
[TBL] [Abstract][Full Text] [Related]
18. Combination of dacarbazine, mitomycin C, 5-fluorouracil and vincristine in advanced colorectal cancer.
Falkson G; Pretorius HL; Falkson HC; Schoeman HS
Cancer Chemother Pharmacol; 1983; 11(3):203-4. PubMed ID: 6416696
[TBL] [Abstract][Full Text] [Related]
19. Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesine.
Garewal HS; Brooks RJ; Jones SE; Miller TP
J Clin Oncol; 1983 Dec; 1(12):772-5. PubMed ID: 6422004
[TBL] [Abstract][Full Text] [Related]
20. [A randomized trial comparing ACF (adriamycin, cyclophosphamide, ftorafur) and ACF/MVMF (mitomycin C, vincristine, methotrexate, ftorafur)--a non-cross-resistant alternating chemotherapy of recurrent and advanced breast cancer].
Mukaiyama T; Ogawa M; Horikoshi N; Inoue K; Tada A; Ueno K; Yamazaki H; Nakamura T; Ito Y; Inagaki J
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):327-32. PubMed ID: 2494947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
